That is very important, due to the fact that the method a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and work. To put it simply, we need to understand how these proteins fold if we want a drug to work. Historically, this has actually been an experimental process (jeff brown prediction for 2021). And now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much simpler to create drugs that do what they're designed to do. This was an advancement nearly no one observed. But it's going to have extensive implications for curing disease. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be a lot of investment opportunities in this space, too. Moving subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (social media). That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be surprised if it pulled back maybe considerably prior to going higher - future report review. I have actually been covering bitcoin for a very long time now. Among the first research study reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were mainly informing readers. But that's not the huge question anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So think of that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. biotech stocks jeff brown. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are many great personal companies on the edge of hitting the general public markets And I've been dealing with a brand-new way for you to invest even before these companies go public.
This opportunity has been building over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the information. Go right here to reserve your spot free of charge.
Emma Walsh here, handling editor of the Journal. Routine Diary readers understand that tech isn't our normal beat (tech stock). And when it comes to tech investing, we leave it to the experts. The good news is, we have several such experts in our Rolodex. Our coworker Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing professionals we understand (second wave). In fact, he had a number of triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge picture and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and much more. These patterns are experiencing rapid development and developing incredible opportunities for investors. I desire to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. jeff brown prediction. However in spite of what many readers might believe, this is a trend that's just getting begun. Although the COVID-19 pandemic interfered with supply chains in 2015, an impressive 250 million 5G-enabled gadgets were still offered.
And all of this ultimately led to Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (the legacy report predictions). Losing two months of manufacturing and sales truly impacts how many 5G devices are offered in the calendar year. When you think about all of that, offering 250 million systems is remarkable. More significantly, the delays brought on by the pandemic developed a lots of bottled-up need. Which demand is now going to be pressed into 2021. In truth, I forecast that more than 500 million 5G devices will be shipped in 2021 - melania trump. And that's not my only 5G prediction When I've spoken about 5G in the past, I've explained its 3 various stages.
In Stage Two, 5G gadgets go on sale. 5G phones and other items start to reach consumers. And in Phase 3, 5G services start to be offered (jeff brown). That's when we start to see applications running on 5G networks. Consider things like huge multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will start Stage Three by this summer. This begins something of a virtuous cycle: Many people don't truly care about the technology. But they will care if there are interesting applications that can only be accessed with a 5G phone.
That causes more 5G apps being developed. In fact, 5G is going to open a suite of incredible applications: self-driving vehicles, the Internet of Things, robotic surgical treatment, and more. All of these technologies require 5G. The investment opportunities going forward will be huge. Stepping away from 5G, the next essential innovation I foresee in 2021 is CRISPR genetic modifying. CRISPR stands for "clustered frequently interspaced short palindromic repeat." It's a mouthful. But it's one of the most exciting developments in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software application.
The program can crash or not function properly. CRISPR uses a comparable idea but with our genetic code. "Typos" in our genome can cause disease. CRISPR can remedy these "typos." For many years, CRISPR was mainly a specific niche technology that wasn't well comprehended. And during that time, there were actually just three business operating in this space. However things are changing. CRISPR is no longer just theoretical. We're seeing actual results. We're dealing with illness and seeing that this innovation simply works. And as a result, a "2nd crop" of early-stage CRISPR companies is going public and delivering incredible returns. This entire industry is efficiently a greenfield opportunity.
There's space for lots of companies to exist in this space. brownstone research. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or three more hereditary modifying business will hold their IPOs. Sticking to biotechnology, we are seeing amazing things taking place at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software application can properly anticipate the folding of a protein based exclusively on its amino acid series with 92. 4% accuracy. That is very important due to the fact that the method a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has actually been an experimental process. Today, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're created to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however numerous drug treatments produced using this innovation. This was among those advancements that nearly no one observed. However it's going to have profound implications for treating disease. And, naturally, there will be a lot of investment opportunities in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be surprised if it drew back maybe substantially before going higher. I have actually been covering bitcoin for a very long time now. One of the very first research study reports I ever released was on bitcoin - brownstone research. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my recommendation. But at the time of that initial suggestion, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
However nobody is asking that concern any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. social media. Mass, Mutual is a 150-year-old organization. So think of that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another reward prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and declares the details depends on date as of February 2021, but we could not separately confirm this claim. Offered Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an accurate figure at this moment. Brown is best known for his sage-like capability to choose winning innovation stocks. He spent more than 25 years researching technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an exceptional perspective on the market. He's always on the hunt for brand-new opportunities, and he shares much of his finest choices in the Near Future Report.
That's high praise, however it's not absurdly reasoned. Brown has an excellent track record as a stock-picker, and he successfully forecasted a few of the biggest economic events of the previous twenty years. Although he doesn't appear to release his picks to the general public, the service's success is a direct sign of Brown's stock-picking prowess. Nobody on Wall Street gets it right every time, but Jeff Brown's accurate predictions have actually earned him legions of dedicated fans. That says a lot about his ability. The Near Future Report is released by Brownstone Research, a popular financial research study publisher. Brownstone Research study uses numerous research services with a wide array of specializations - united arab emirates.
The business is likewise connected with Bonner & Partners, another well-respected research publisher - social media. On its site, Brownstone states its objective is to supply retail investors with professional-grade research study: "For too long, the best financial investment research study has actually not been readily available to private financiers. It has actually been normally reserved for investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown biotech picks. The objective of Brownstone Research study is to make that type of exclusive research available to any financiers seeking to acquire an edge in the marketplaces. The objective is basic to provide distinct and lucrative financial investment research discovered nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also serves as the firm's Chief Investment Analyst.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to use its clients. After decades of stable success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout the majority of America. If you know even a little bit about the marketplace, you understand that he has a credibility as a King Midas of sorts. last year. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In truth, Brown thinks S.A.V. longtime readers. could be "the greatest trend of the 2020s, and he's not alone. Take a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be weding 2 cutting-edge innovations: synthetic intelligence and electric automobiles. Musk hopes the mix will assist him establish the very first fully-autonomous, self-driving cars ever. It's nothing brief of the automobile market's Holy Grail. As you understand, electric vehicles and self-driving automobile stocks have actually been huge this year, but the Wall Street maker has been huge on buzz without much tangible result. Despite a drastic boost in competition over the past few years, Brown still believes Musk has the very best possibility of putting it all together.
tech could be the magic string that connects it all together. S.A.V. represents Shared Autonomous Vehicle, and it could be the future of transportation. Basically, this innovation would enable you to rent out your vehicle as a self-governing, self-driving taxi when you're not using it. You just get out of the car and press a button on an app that tells the vehicle to "join the fleet." Next thing you know, you're relaxing on your couch while your car shuttles ride-sharers around town. Best of all, you get to keep a substantial piece of the earnings. It sounds crazy, but it could be closed than you believe.